Spacer   Spacer
Logo neurotune
  neurotune home
blauer Punkt

Neurotune wins Award
Neurotune wins ZKB Pioneer Award TECHNOPARK 2007
BIld neurotune
Spacer Spacer
Neurotune, based in Schlieren (Zurich), Switzerland, was incorporated in January 2005 as a spin-off from Prionics AG.

Neurotune develops small-molecular drugs to treat disorders of the human peripheral and central nervous system, as well as drugs to treat age-related muscle atrophy – Sarcopenia.

The enormous economic potential of novel drugs for the treatment of central nervous system disorders lays ground for a successful development of the company.

The scope of activities at Neurotune is
Spacer
Rechteck
drug development from preclinical R&D up to clinical Phase II
Spacer
Rechteck
out-licensing at the stage of clinical Phase II
Spacer
Rechteck
in-licensing of drug candidates

Our core competences lie in
Spacer
Rechteck
biochemistry, neurological disorders of the central and peripheral
nervous system
Spacer
Rechteck
medicinal chemistry on small molecular drugs
Linie
Spacer